Salerno Pharmaceuticals Co

FDA Filings

This page includes the latest FDA filings for Salerno Pharmaceuticals Co. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device Company	Device	Date
FloLipid Salerno Pharmaceuticals Co., Rosemont Pharmaceuticals Ltd	Prescription Medication	2023-02-10
FloLipid Salerno Pharmaceuticals Co., Rosemont Pharmaceuticals Ltd	Prescription Medication	2023-01-18
FloLipid Salerno Pharmaceuticals Co., Rosemont Pharmaceuticals Ltd	Prescription Medication	2022-02-05
FloLipid Salerno Pharmaceuticals Co., Rosemont Pharmaceuticals Ltd	Prescription Medication	2020-10-08
NDC 29273-402 Salerno Pharmaceuticals Co.	FloLipid	2017-11-01
NDC 29273-401 Salerno Pharmaceuticals Co.	FloLipid	2017-11-01
FloLipid Salerno Pharmaceuticals Co., Rosemont Pharmaceuticals Ltd	Prescription Medication	2017-11-01

Similar & Related FDA Registered Companies

Rosemont Pharmaceuticals Ltd

Related Finance Registrations

NCAGE Code	8DXY5	SALERNO PHARMACEUTICALS CO.
CAGE Code	8DXY5	SALERNO PHARMACEUTICALS CO.
S.A.M. Registration	8DXY5 [963714766]	SALERNO PHARMACEUTICALS CO.
DUNS	963714766	Salerno Pharmaceuticals Co.

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.